Clinical trial
An Open, Single-center, Phase II Clinical Trial Evaluating the Efficacy of PD-1 Antibody (JS001) in Combination With Neoadjuvant Chemotherapy for Gastric/Gastroesophageal Junction Cancer
NCT05033392 is registered in ClinicalTrials.gov with Wan He as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open, Single-center, Phase II Clinical Trial Evaluating the Efficacy of PD-1 Antibody (JS001) in Combination With Neoadjuvant Chemotherapy for Gastric/Gastroesophageal Junction Cancer
- Lead sponsor
- Wan He
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- September 14, 2021
- Completion date
- December 31, 2027
- Enrollment
- 62 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.